日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial

宫颈鳞状细胞癌新辅助放化疗前免疫检查点阻断治疗(GINECO 机会窗口 COLIBRI 研究):一项 II 期试验

Ray-Coquard, Isabelle; Kaminsky-Forrett, Marie-Christine; Ohkuma, Ryotaro; de Montfort, Aymeric; Joly, Florence; Treilleux, Isabelle; Ghamry-Barrin, Sarah; Bello-Roufai, Diana; Saintigny, Pierre; Angelergues, Antoine; Michon, Lucas; Hardy-Bessard, Anne-Claire; Attignon, Valéry; Auclair, Jessie; Chemin, Gabriel; Lainé, Alexandra; Péré, Hélène; Veyer, David; Savoye, Aude-Marie; Berthet, Justine; Caux, Christophe; Lecuru, Fabrice; Dubois, Bertrand; Bétrian, Sarah

Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2.

III 型干扰素可使 pDC 启动 TLR7 激活,并拮抗 TGF-β 和 PGE2 介导的免疫抑制

Sakref Candice, Saby Alexis, Rodriguez Céline, Ardin Maude, Moudombi Lyvia, Doffin Anne-Claire, Gobbini Elisa, Voissiere Aurélien, Besson Laurie, Laoubi Léo, Böttcher Jan, Depil Stéphane, Hubert Margaux, Bendriss-Vermare Nathalie, Caux Christophe, Valladeau-Guilemond Jenny

Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2

III型干扰素可启动pDCs的TLR7激活,并拮抗TGF-β和PGE2介导的免疫抑制。

Candice Sakref #,Alexis Saby #,Céline Rodriguez,Maude Ardin,Lyvia Moudombi,Anne-Claire Doffin,Elisa Gobbini,Aurélien Voissiere,Laurie Besson,Léo Laoubi,Jan Böttcher,Stéphane Depil,Margaux Hubert ,Nathalie Bendriss-Vermare,Christophe Caux ,Jenny Valladeau-Guilemond

Interleukin-35 impairs human NK cell effector functions and induces their ILC1-like conversion with tissue residency features

白细胞介素-35会损害人NK细胞的效应功能,并诱导其向具有组织驻留特征的ILC1样细胞转化。

Valentin Picant # ,Lara Revol-Bauz # ,Laurie Tonon ,Timothée Casini ,Aurélien Voissière ,Dominique Poujol ,Emilie Picard ,Céline Rodriguez ,Cyril Degletagne ,Emily Sible ,Uzma Hasan ,Anthony Ferrari ,Christophe Caux ,Nathalie Bendriss-Vermare

Optimizing Pemphigus Management With Rituximab and Short-Term Relapse Predictors

利用利妥昔单抗和短期复发预测因子优化天疱疮治疗

Hébert, Vivien; Hamwi, Sami; Tancrède-Bohin, Emmanuelle; Quéreux, Gaelle; Pham-Ledard, Anne; Caux, Frédéric; Tedbirt, Billal; Lefebvre, Alexis; Cordel, Nadège; Alexandre, Marina; Viguier, Manuelle; Jeudy, Géraldine; D'Incan, Michel; Debarbieux, Sébastien; Brue, Alexis; Duvert-Lehembre, Sophie; Fenot, Marion; Seta, Vannina; Ingen-Housz-Oro, Saskia; Lepelletier, Clémence; Joly, Pascal

Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris

利妥昔单抗治疗落叶型天疱疮与寻常型天疱疮的长期疗效和安全性比较

Tedbirt, Billal; Houivet, Estelle; Maho-Vaillant, Maud; Golinski, Marie-Laure; Calbo, Sébastien; Prost-Squarcioni, Catherine; Labeille, Bruno; Picard-Dahan, Catherine; Chaby, Guillaume; Richard, Marie-Aleth; Tancrède-Bohin, Emmanuelle; Duvert-Lehembre, Sophie; Delaporte, Emmanuel; Bernard, Philippe; Caux, Frédéric; Alexandre, Marina; Musette, Philippe; Ingen-Housz-Oro, Saskia; Vabres, Pierre; Quereux, Gaëlle; Dupuy, Alain; Debarbieux, Sébastien; Avenel-Audran, Martine; D'Incan, Michel; Bédane, Christophe; Bénéton, Nathalie; Jullien, Denis; Dupin, Nicolas; Misery, Laurent; Machet, Laurent; Beylot-Barry, Marie; Dereure, Olivier; Sassolas, Bruno; Cordel, Nadège; Jeudy, Géraldine; Benichou, Jacques; Hébert, Vivien; Joly, Pascal

Tumor-stroma proportion on primary tumor as a prognostic biomarker in advanced ovarian cancer patients receiving chemo-immunotherapy as first-line therapy: analyses from the NeoPembrOV/GINECO phase II randomized trial

肿瘤间质比例作为接受化疗-免疫疗法一线治疗的晚期卵巢癌患者的预后生物标志物:来自 NeoPembrOV/GINECO II 期随机试验的分析

Collet, L; Noël, J-C; Catteau, X; Ardin, M; Berthet, J; Ghamry-Barrin, S; Treilleux, I; Bengrine Lefevre, L; Martinez, M; Rothé, F; Sotiriou, C; Caux, C; Dubois, B; Ray-Coquard, I; Le Saux, O

Dendritic cells: the central partner for cancer immunity

树突状细胞:癌症免疫的核心伙伴

Laoubi, Léo; Gobbini, Elisa; Duplouye, Pierre; Hubert, Margaux; Caux, Christophe; Bendriss-Vermare, Nathalie; Valladeau-Guilemond, Jenny; Voissière, Aurélien

Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy

子宫内膜癌中的免疫微环境和肿瘤相关巨噬细胞密度:对免疫检查点抑制剂疗效的影响

Le Saux, Olivia; Sabatier, Renaud; Treilleux, Isabelle; Renaud, Léa-Isabelle; Brachet, Pierre-Emmanuel; Martinez, Alejandra; Frenel, Jean-Sébastien; Abdeddaim, Cyril; Berthet, Justine; Barrin, Sarah; Colombe-Vermorel, Amélie; Odeyer, Laetitia; Lainé, Alexandra; Caux, Christophe; Dubois, Bertrand; Ray-Coquard, Isabelle

Third-Generation CD73 Inhibitors Based on a 4,6-Disubstituted-2-Thiopyridine Scaffold

基于4,6-二取代-2-噻吩吡啶骨架的第三代CD73抑制剂

Grosjean, Félix; Shaldaeva, Maria; Cros-Perrial, Emeline; Rodriguez, Céline; Ghoteimi, Rayane; Lebrun, Aurélien; Gao, Zhan-Guo; Uttaro, Jean-Pierre; Mathé, Christophe; Jacobson, Kenneth A; Petter Jordheim, Lars; Ménétrier-Caux, Christine; Chaloin, Laurent; Peyrottes, Suzanne